Alopecia Areata
Alopecia Areata is an autoimmune condition that causes sudden hair loss in patches, affecting both men and women. It occurs when the immune system mistakenly attacks hair follicles.
Autoimmune Diseases: VIS171 Treatment
We are testing a new treatment called VIS171 for individuals with autoimmune diseases. The study aims to evaluate its safety and how the body reacts to it.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs, leading to symptoms like fatigue, joint pain, and skin rashes.
Immune-Mediated Focal Segmental Glomerulosclerosis
Immune-mediated focal segmental glomerulosclerosis (FSGS) is a rare kidney disease characterized by scarring in the kidney's filtering units, which can lead to kidney failure.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Multispecialty hospital for active treatment Sveta Sofia EOOD
Department of Dermatology and Venereology
Sofia, Bulgaria
University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD
Department of Rheumatology
Sofia, Bulgaria
Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher
Centrum Wsparcia Badań Klinicznych
Ochota, Poland
Sponsor: Otsuka Pharmaceutical Development & Commercialization Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.